|
Real-time Estimate
Cboe BZX
14:29:21 2026-11-02 EST
|
5-day change | 1st Jan Change | ||
| 2.405 USD | -5.31% |
|
+11.37% | +47.24% |
| 10-06 | Guggenheim Initiates Ovid Therapeutics at Buy | MT |
| 09-20 | Ovid Therapeutics Inc.(NasdaqCM:OVID) added to S&P Global BMI Index | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 496M | - | - | - | ||
| 63.77B | |||||
| 56.37B | |||||
| 54.62B | |||||
| 44.06B | |||||
| 42.11B |
Select your edition
All financial news and data tailored to specific country editions
